Category Archives: Hologic Inc.

Aptima® HIV-1 Quant Dx Assay Awarded World Health Organization Prequalification

MARLBOROUGH, Massachusetts, Jan. 16, 2018 /PRNewswire/ — Hologic, Inc. (Nasdaq: HOLX) announced today that its CE-marked Aptima® HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostics. The Aptima HIV-1 Quant Dx assay, employing Hologic’s proprietary real-time transcription-mediated amplification (TMA) technology, is the first HIV-1 viral load assay with […]